PTPRC and plasma cell myeloma: In their studies, different populations of MM cells were distinguished by their CD45 expression: primitive (CD38hiCD45hi) and immature (CD38hiCD45lo) myeloma cells had higher CD86 levels than mature (CD38hiCD45neg) myeloma cells, while patients with mature myeloma cells had poorer prognoses.69, 72